Rapt Therapeutics Inc RAPT:NASDAQ

Last Price$13.43NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-1.44(9.68%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$13.26 - 14.80
Volume424.7 K
 

View Biotechnology IndustryPeer Comparison as of 05/18/2022

 

Rapt Therapeutics Inc ( NASDAQ )

Price: $13.43
Change: -1.44 (9.68%)
Volume: 424.7 K
4:00PM ET 5/18/2022
 
 

Agenus Inc ( NASDAQ )

Price: $1.53
Change: -0.12 (7.27%)
Volume: 4.4 M
4:00PM ET 5/18/2022
 
 

MiMedx Group Inc ( NASDAQ )

Price: $3.64
Change: -0.30 (7.61%)
Volume: 543.0 K
4:00PM ET 5/18/2022
 
 

Vaxart Inc ( NASDAQ )

Price: $3.16
Change: -0.22 (6.51%)
Volume: 2.8 M
4:00PM ET 5/18/2022
 
 

Protagonist Therapeutics Inc ( NASDAQ )

Price: $7.85
Change: -0.76 (8.83%)
Volume: 1.7 M
4:00PM ET 5/18/2022
 

Read more news Recent News

--Piper Sandler Lowers RAPT Therapeutics Price Target to $30 From $52, Maintains Overweight Rating
12:35PM ET 5/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (RAPT) RAPT THERAPEUTICS Posts Q1 Revenue $641,000
8:04AM ET 5/11/2022 MT Newswires

...

RAPT Therapeutics Says Skin Disease Treatment Trial Data Shows 'Significant Improvement' in Efficacy Measures
11:07AM ET 3/28/2022 MT Newswires

RAPT Therapeutics (RAPT) said Monday results from a phase 1b clinical trial of its RPT193 oral treatment in patients with moderate-to-severe atopic...

Wells Fargo Adjusts RAPT Therapeutics' Price Target to $55 from $65, Reiterates Overweight Rating
12:08PM ET 3/11/2022 MT Newswires

RAPT Therapeutics (RAPT) has an average rating of outperform and price targets ranging from $52 to $72, according to analysts polled by Capital IQ. (MT...

View all Commentary and Analysis

Rapt Therapeutics (RAPT) Investor Presentation - Slideshow
12:55PM ET 11/19/2021 Seeking Alpha

RAPT Therapeutics (RAPT) Investor Presentation - Slideshow
2:38PM ET 10/01/2021 Seeking Alpha

RAPT Therapeutics (RAPT) RPT193 2021 EADV Congress Presentation - Slideshow
2:37PM ET 10/01/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
11:13PM ET 6/18/2021 Seeking Alpha

Company Profile

Business DescriptionRapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA. View company web site for more details
Address561 Eccles Avenue
South San Francisco, California 94080
Phone+1.650.489.9000
Number of Employees64
Recent SEC Filing05/12/20224
President, Chief Executive Officer & DirectorBrian Russell Wong
Chief Financial Officer & SecretaryRodney K. B. Young
Chief Medical OfficerWilliam Ho
Chief Scientific OfficerDirk G. Brockstedt

Company Highlights

Price Open$14.25
Previous Close$13.43
52 Week Range$9.86 - 43.26
Market Capitalization$398.1 M
Shares Outstanding29.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.53
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit Margin-1,814.95%
Return on Equity-39.69%

Analyst Ratings as of 03/25/2022

Buy
8
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset